Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging facilities with efficient operating models primarily in the upscale segment of the lodging industry. As of February 24, 2025, the Company's portfolio consisted of 97 assets, 53 of which are wholly owned, with a total of 14,553 guestrooms located in 25 states.

Summit Hotel Properties Inc.

RBC Capital analyst Rowland Mayor maintained a Hold rating on American International Group yesterday and set a price target of $85.00. According to...

American International Group (AIG) Gets a Hold from RBC Capital

In a report released today, Jason Napier from UBS maintained a Buy rating on ING GROEP, with a price target of €28.50. Napier covers the Financial ...

UBS Keeps Their Buy Rating on ING GROEP (0RIC)

In a report released yesterday, Thaninee Satiraruengchai from DBS maintained a Buy rating on ING GROEP, with a price target of €30.00. The company’...

DBS Sticks to Their Buy Rating for ING GROEP (0RIC)

Amplia Therapeutics ( ($AU:ATX) ) has provided an announcement. Amplia Therapeutics has paused further recruitment in its AMPLICITY clinical trial ...

Amplia Halts New Recruitment in Pancreatic Cancer Trial After Chemo Toxicities

Amplia Therapeutics ( ($AU:ATX) ) has shared an update. Amplia Therapeutics has halted further recruitment in its AMPLICITY trial in advanced pancr...

Amplia Halts AMPLICITY Recruitment, Shifts Focus to Less Toxic Pancreatic Cancer Regimens

WSW, NY, April 6th, 2026, FinanceWire The race to build quantum computers is accelerating. Governments are investing billions, major technology com...

Inspira’s Quantum Play Could Position It as a “Picks and Shovels” Opportunity in a Multi-Billion Dollar Market

Inspira Technologies Oxy BHN ( ($IINN) ) has issued an announcement. On April 6, 2026, Israel‑based Inspira Technologies announced its entry into t...

Inspira Technologies Repositions as QTREX With Quantum Connectivity Push

The latest announcement is out from InnoCan Pharma ( ($TSE:INNO) ). Innocan Pharma has closed an additional US$200,000 secured debenture financing ...

Innocan Pharma Secures Additional Insider Debenture Ahead of Planned U.S. Offering

An update from Inspira Technologies Oxy BHN ( ($IINN) ) is now available. On April 1, 2026, Inspira Technologies Oxy B.H.N. Ltd. signed an asset pu...

Inspira Technologies Closes $12.5 Million Acquisition of Nano Dimension’s AME Platform

In a report released on April 2, Benoit Petrarque from Kepler Capital maintained a Buy rating on ING GROEP, with a price target of €32.20. The comp...

ING GROEP (0RIC) Receives a Rating Update from a Top Analyst

In a report released today, from DBS downgraded ING GROEP to a Hold, with a price target of €28.00. In addition to DBS, ING GROEP also received a H...

DBS downgrades ING GROEP (0RIC) to a Hold

ING Groep ( ($ING) ) has issued an update. On March 23, 2026, ING Groep N.V. filed a Form 6-K detailing an underwriting agreement dated March 16, 2...

ING Groep Prices $3 Billion in Callable U.S. Senior Notes Due 2032 and 2037

InnovAge Holding ( ($INNV) ) just unveiled an announcement. InnovAge Holding Corp. told investors it plans to meet with investors and analysts at t...

InnovAge Holding to Reiterate Fiscal 2026 Guidance Outlook

In a report released today, Jason Napier from UBS maintained a Buy rating on ING GROEP, with a price target of €27.40. Napier covers the Financial ...

UBS Reaffirms Their Buy Rating on ING GROEP (0RIC)

InnoCan Pharma ( ($TSE:INNO) ) has issued an update. Innocan Pharma plans to issue a US$450,000 secured debenture to its largest shareholder, Tamar...

Market Cap	$611.47M	P/E Ratio	5.96
52W High	$6.00	52W Low	$3.57
Div Yield	32.0%	Payout Ratio	544.0%
EPS Growth 3Y	31.8%	52W Position	46.7%
Overall Score	56	Value Score	80
Quality Score	50	Technical Score	40

EPS Current Est	$0.79	EPS Next Est	$0.8
EPS Growth Est	+1.3%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INN	$4.71	-0.74%	364.51K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INN	$4.71	-0.7%	364.51K
3
4
5
6

INN

INN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Summit Hotel Properties Inc. Data in Excel

Get Summit Hotel Properties Inc. Data in Excel